These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31020271)

  • 1. Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports.
    Kobayashi T; Ito S; Murasawa A; Ishikawa H; Yoshie H
    BMC Rheumatol; 2019; 3():13. PubMed ID: 31020271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors.
    Kobayashi T; Ito S; Kobayashi D; Kojima A; Shimada A; Narita I; Murasawa A; Nakazono K; Yoshie H
    Clin Exp Dent Res; 2015 Dec; 1(2):63-73. PubMed ID: 29744142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis.
    Kobayashi T; Okada M; Ito S; Kobayashi D; Ishida K; Kojima A; Narita I; Murasawa A; Yoshie H
    J Periodontol; 2014 Jan; 85(1):57-67. PubMed ID: 23489234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
    Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
    J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
    Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
    J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis.
    Kobayashi T; Yoshie H
    Curr Oral Health Rep; 2015; 2(1):1-8. PubMed ID: 25657893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
    Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
    J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.
    Ortiz P; Bissada NF; Palomo L; Han YW; Al-Zahrani MS; Panneerselvam A; Askari A
    J Periodontol; 2009 Apr; 80(4):535-40. PubMed ID: 19335072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary TNFα levels in groups of subjects with rheumatoid arthritis and chronic periodontitis.
    Gamel EB; Hashim NT; Satti A; Gismalla BG
    BMC Res Notes; 2017 Jan; 10(1):34. PubMed ID: 28061876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis.
    Migita K; Izumi Y; Jiuchi Y; Kozuru H; Kawahara C; Izumi M; Sakai T; Nakamura M; Motokawa S; Nakamura T; Kawakami A
    Clin Exp Immunol; 2014 Feb; 175(2):208-14. PubMed ID: 24665995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
    Kawaguchi Y; Waguri-Nagaya Y; Tatematsu N; Oguri Y; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
    Clin Exp Rheumatol; 2018; 36(4):559-567. PubMed ID: 29352846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.
    Hamar A; Szekanecz Z; Pusztai A; Czókolyová M; Végh E; Pethő Z; Bodnár N; Gulyás K; Horváth Á; Soós B; Bodoki L; Bhattoa HP; Nagy G; Tajti G; Panyi G; Szekanecz É; Domján A; Hodosi K; Szántó S; Szűcs G; Szamosi S
    Osteoporos Int; 2021 Aug; 32(8):1621-1629. PubMed ID: 33559714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis.
    Kaur S; Bright R; Proudman SM; Bartold PM
    Semin Arthritis Rheum; 2014 Oct; 44(2):113-22. PubMed ID: 24880982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea.
    Choi IA; Kim JH; Kim YM; Lee JY; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
    Korean J Intern Med; 2016 Sep; 31(5):977-86. PubMed ID: 27017391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-1 and Fcgamma receptor gene polymorphisms in Japanese patients with rheumatoid arthritis and periodontitis.
    Kobayashi T; Ito S; Kuroda T; Yamamoto K; Sugita N; Narita I; Sumida T; Gejyo F; Yoshie H
    J Periodontol; 2007 Dec; 78(12):2311-8. PubMed ID: 18052703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.
    Vyas D; O'Dell KM; Bandy JL; Boyce EG
    Ann Pharmacother; 2013 Nov; 47(11):1524-31. PubMed ID: 24285764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients.
    Bıyıkoğlu B; Buduneli N; Aksu K; Nalbantsoy A; Lappin DF; Evrenosoğlu E; Kinane DF
    Rheumatol Int; 2013 Oct; 33(10):2607-16. PubMed ID: 23728274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
    Havemose-Poulsen A; Westergaard J; Stoltze K; Skjødt H; Danneskiold-Samsøe B; Locht H; Bendtzen K; Holmstrup P
    J Periodontol; 2006 Feb; 77(2):280-8. PubMed ID: 16460255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.